Abstract:Cardiovascular diseases, the major international health problem and the leading cause of death worldwide have been increasing in recent years due to population aging and lifestyle changes. Loss of cardiac muscle function after myocardial damage is one of the most critical challenges in cardiovascular medicine that has not yet been overcome. Tissue engineering (TE) has emerged as a promising therapeutic approach in modern medicine, targeting the substitution of damaged tissue with functional tissue grown inside an artificial scaffold. Great efforts have been made toward the construction of tissue engineering scaffolds that paved the way for extracellular matrix (ECM)‐like biomaterial. In cardiac tissue engineering, key parameters must be determined to select the ideal biomaterial, such as biocompatibility, conductivity, mechanical features, degradation and swelling rate, surface properties, and cell viability, growth and proliferation. Among different scaffolding materials, a wide range of natural biological macromolecules and synthetic macromolecules have been utilized to produce scaffolds with multifunctionality for cardiac tissue engineering (CTE). In this review, we have focused on recent achievements in the field of synthetic biodegradable macromolecules (such as aliphatic polyesters, polyurethane, poly (glycerol sebacate)) and the significant strategies to construct electrically conductive scaffolds to regenerate the function of native cardiac tissue. These biodegradable macromolecules have several attractive properties, including biocompatibility, elasticity, good mechanical properties, compatibility with native cardiac tissue, and proper surface biochemistry to increase cardiac cell adhesion, making them appropriate candidates for CTE. Recently, a growing trend in the use of conductive scaffolds for cardiac regeneration has been witnessed. Different materials ranging from metals, ceramics, and polymers have been used as parts of conductive scaffolds for CTE, possessing conductivity assortments from a range of semiconductive to conductive. Moreover, this review paper also focuses on the main strategies to create electroconductive scaffolds for in vitro cardiac muscle regeneration.

Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering

Extracellular matrix-based materials for regenerative medicine

Hybrid cardiovascular sourced extracellular matrix scaffolds as possible platforms for vascular tissue engineering

Natural ECM as Biomaterial for Scaffold Based Cardiac Regeneration Using Adult Bone Marrow Derived Stem Cells

Extracellular Matrix Scaffolds for Tissue Engineering and Regenerative Medicine

Decellularized extracellular matrix: New promising and challenging biomaterials for regenerative medicine

Exploiting the Potential of Decellularized Extracellular Matrix (ECM) in Tissue Engineering: A Review Study

Biomaterials in myocardial tissue engineering

Engineering Collagen-Based Biomaterials for Cardiovascular Medicine

A Three-Dimensional Collagen-Elastin Scaffold for Heart Valve Tissue Engineering

Advances in three-dimensional bioprinted stem cell-based tissue engineering for cardiovascular regeneration

Biomaterial Based Cardiac Tissue Engineering and Its Applications

Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective

The extracellular matrix mechanics in the vasculature

Artificial Cardiac Muscle with or without the Use of Scaffolds

Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering

Evolution of biomimetic ECM scaffolds from decellularized tissue matrix for tissue engineering: A comprehensive review

Decellularized extracellular matrix biomaterials for regenerative therapies: Advances, challenges and clinical prospects

Biodegradable functional macromolecules as promising scaffolds for cardiac tissue engineering

Decellularized extracellular matrix scaffolds: Recent trends and emerging strategies in tissue engineering

Use of human aortic extracellular matrix as a scaffold for construction of a patient-specific tissue engineered vascular patch.